Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study

por Bhushan B L, Shashi, Wanve, Sunil, Koradia, Parshottam, Bhomia, Vinay, Soni, Pravin, Chakraborty, Sisir, Khobragade, Akash, Joshi, Shashank, Mendiratta, Sanjeev Kumar, Kansagra, Kevin Kumar, Parihar, Anurag, Sharma, Sunil, Patel, Jatin
Publicado 2021

ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection

por Yadav, Pragya D., Mendiratta, Sanjeev Kumar, Mohandas, Sreelekshmy, Singh, Arun K., Abraham, Priya, Shete, Anita, Bandyopadhyay, Sanjay, Kumar, Sanjay, Parikh, Aashini, Kalita, Pankaj, Sharma, Vibhuti, Pandya, Hardik, Patel, Chirag G., Patel, Mihir, Soni, Swagat, Giri, Suresh, Jain, Mukul
Publicado 2021

Rituximab biosimilar for the treatment of diffuse large B-cell lymphoma: a phase 3 randomized study in India

por Patel, Ankit, Bhatt, Niraj, Prakash, S. S., Biswas, Ghanashyam, Nagarkar, Rajnish, Roy, Bodhisatta, Samal, Priyanka, Agrawal, Narendra, Meshram, Sushil, Kaushal, Ashish, Satheesh, C. T., Wategaonkar, Ravikumar, Thiagarajan, Kasi Viswanathan, Jain, Kartikeya, Vijayaveeran, P., Mukherjee , Kalyan, Singh, Kishore, Patil, Tushar, Jain, Amit, Dolai, Tuphan Kanti, Jain, Minish, Hingmire, Sachin, Gupta, Tara Chand, Lakshmaiah, K. C., Rajamanickam, Deepan, Nemade, Bhushan, Goyal, Vikash, Mahato, Pinaki, Mendiratta, Sanjeev Kumar, Doshi, Maulik
Publicado 2023